Rigshospitalet
Copenhagen, Østerbro, 2100, Denmark
NCT Number: NCT00967109
The purpose of this study is to determine whether a higher threshold for transfusion with red blood cells improves the tissue oxygenation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Copenhagen, Østerbro, 2100, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Transfusion with red blood cells to hemoglobin level between 4,5-5,5 mmol/L
Transfusion with red blood cells to hemoglobin level between 5,6-6,5 mmol/L
Time frame: Every fifteen minutes throughout surgery
The primary endpoint is the change in subcutaneous oxygen tension from incision until the time most patients is still undergoing surgery. Subcutaneous oxygen tension is measured every fifteen minutes throughout surgery. The oxygen tension is measured with a polygraphic electrode (Clark's electrode).
Time frame: Every fifteen minutes throughout surgery
Time frame: Every half an hour throughout surgery
Time frame: Every fifteen minutes throughout surgery
Time frame: Every fifteen minutes throughout surgery
The change in muscular saturation from incision until the time when most patientes are still undergoing surgery. Furthermore the lowest measured and the last measured muscular saturation is also evaluated.
Time frame: Every fifteen minutes throughout surgery
The lowest measured subcutaneous oxygen tension and the last measured subcutaneous oxygen tension throughout surgery.
Looking for future studies?
Notify MeRigshospitalet, Denmark
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03459287
Anemia, Hematologic Diseases
Los Angeles, California, United States
View Trial DetailsNCT03558464
Anemia, Growth Disorders
Kakamega, Kenya
View Trial DetailsNCT05889052
Anemia, Hematologic Diseases
Soa and Mbankomo, Cameroon
View Trial DetailsNCT05856357
Anemia, Hematologic Diseases
Séguéla, Côte d’Ivoire
View Trial Details